Omvoh's approval as a treatment for Crohn's disease was based on results from a study in which 53% of patients treated with the drug achieved clinical remission, and 46% of patients had visible ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Some other medicines that are slated to become blockbusters in the near future include GSK’s vaccine candidate GSK-3536819 ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

A notorious Japanese serial killer known as the “Black Widow” was found lying on her back in her cell while awaiting execution. Chisako Kakashi, 78, was confirmed dead after being found lying ...

Missiles have become the leading cause of death among airline passengers with more than 500 cases recorded in the last decade, the most recent of which was the Azerbaijan Airlines allegedly shot ...

Jetliners being accidentally blasted out of the sky has become the leading cause of commercial-aviation deaths over recent years, marking a new trend running counter to an otherwise improving ...

The killer messaged Mr Rae: "Bro listen I’m coming now, if you ain’t got the bread by [when] I get there, it’s long.” Describing the attack to the jury prosecutor Christopher Rees said ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

Eli Lilly (LLY) closed at $795.67 in the latest trading session, marking a -0.08% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 1.1%. Elsewhere ...

How can the Dems point to January 6th offenders, with a straight face, and say they, compared to child killers ... I feel your pain.' With Biden, it's the other way around. He is going to make ...